The Pearl clinical study will recruit 3000 patients with high-risk conditions for liver cancer with the aim of detecting liver cancer earlier as part of the Cancer Research UK-funded DeLIVER programme.
As part of World Cancer Day 2022 we are diving into 10 of Oxford\u2019s most impactful historical and modern contributions to the field of cancer science and treatment. Read more about what Oxford researchers have done to shape this ever-important area of medical science.
Toral Gathani has been awarded a prestigious Hunterian Professorship (2022) by the Royal College of Surgeons of England. The award recognises her work on ethnicity and breast cancer.
New research into the onset of diabetes which could go on to help in the early diagnosis of pancreatic cancer is being led by scientists at the University of Oxford.
Dr Christiana Kartsonaki and colleagues from the China Kadoorie Biobank have identified several proteins in the blood that are associated with an increased risk of pancreatic cancer.
Radiologists at Oxford University Hospitals (OUH) NHS Foundation Trust & University of Oxford have set up a new company aimed at helping to improve the interpretation of medical imaging by clinicians, for many conditions including cancer.
Oxford University spin-out Optellum have announced their collaboration with GE Healthcare to advance lung cancer diagnosis using artificial intelligence.
Reducing chronic infections from the bacterium Helicobacter pylori would be a key strategy for preventing stomach cancer, according to research published today. To generate conclusive evidence, Oxford researchers used high-quality data from the prospective China Kadoorie Biobank (CKB) study.
Research from Dr Brian Nicholson and colleagues outlines how routine clinical tests could be widely used to estimate the risk of cancer for people visiting their GPs with unexpected weight loss.
Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett\u2019s oesophagus and so determine patients most at risk of developing cancer.
A new calculator has been developed by Professors Julia Hippisley-Cox and Carol Coupland to help GPs prioritise patients at high risk of prostate cancer.
Dr Francesco Boccellato is investigating the mechanisms of tissue regulation in the healthy stomach and in a pre-cancerous condition known as atrophic gastritis. This may help to identify those who may have cancer, as well as find new ways to prevent cancer from progressing
Professor Eric O\u2019Neill and Dr Pui San Tan receive funding as part of teams applying novel approaches for the early detection of pancreatic cancer.
Dr Onima Chowdhury will investigate the clinical application of single cell sequencing for early diagnosis and response prediction in myelodysplastic syndromes.
Dr Defne Saatci and Professor Julia Hippisley-Cox will develop risk prediction tools using the QResearch database to support the earlier detection of childhood, teenage and young adult cancer
New research from the Nuffield Department of Population Health shows that reducing alcohol consumption in China could be an important cancer prevention strategy
![\"Pearl](\"https://www.cancer.ox.ac.uk/news/first-major-uk-prospective-study-for-liver-cancer-underway/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n